Gross Profit On Sales Cambiamento Data
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
ANI Pharmaceuticals USD 78.23M 5.49M 2023-12
Ardelyx USD 48.7M 29.85M 2023-09
Aurora Cannabis CAD 11.94M 34.41M 2023-03
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Corcept Therapeutics USD 121.96M 5.82M 2023-09
Eli Lilly USD 7.57B 73.1M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
J&J USD 14.6B 374M 2023-12
Knight Therapeutics CAD 40.18M 2.69M 2023-09
Lexicon Pharmaceuticals USD 155K 154K 2023-09
Merck USD 11.29B 441M 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Omeros USD 29.67M 1.19M 2021-09
Pacira USD 133.55M 9.38M 2023-12
Pfizer USD 7.58B 3.26B 2023-12
Supernus Pharmaceuticals USD 144.69M 10.41M 2023-12
TG Therapeutics USD 36.12M 126.19M 2023-12



Corcept Therapeutics Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.